COM:GENERATIONBIO
Generation Bio Co.
- Stock
Last Close
1.35
21/11 21:00
Market Cap
155.01M
Beta: -
Volume Today
185.51K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 1.97M - | 1.26M 35.96% | 1.15M 9.05% | 1.34M 17.25% | 1.50M 12.03% | ||
average receivables | 868K - | 224K 74.19% | 197.50K - | 197.50K 0% | |||
book value per share | -2.11 - | -3.14 48.72% | 9.83 413.06% | 6.78 31.04% | 4.86 28.32% | 0.00 99.94% | |
capex per share | -0.15 - | -0.64 315.05% | -0.20 68.20% | -0.11 47.72% | -0.15 43.09% | -0.00 99.92% | |
capex to depreciation | -8.71 - | -10.72 23.16% | -1.61 85.00% | -1.31 18.23% | -1.72 30.50% | 1.81 205.75% | |
capex to operating cash flow | 0.11 - | 0.50 361.08% | 0.08 84.12% | 0.06 17.52% | 0.09 32.39% | 0.14 63.25% | |
capex to revenue | -83.92 - | -1.25 - | |||||
cash per share | 3.80 - | 0.48 87.37% | 9.62 1,903.85% | 6.66 30.76% | 4.80 27.93% | 0.00 99.91% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 13.06K - | ||||||
debt to assets | 0.17 - | 0.22 28.09% | 0.26 20.29% | ||||
debt to equity | 0.21 - | 0.29 36.61% | 0.48 66.62% | ||||
dividend yield | |||||||
earnings yield | -0.07 - | -0.08 5.72% | -0.10 27.17% | -0.29 190.60% | -0.58 101.03% | -0.00 99.79% | |
enterprise value | 478.90M - | 759.92M 58.68% | 709.83M 6.59% | 104.25M 85.31% | 216.93M 108.08% | 106.43B 48,962.13% | |
enterprise value over ebitda | -12.96 - | -12.57 3.00% | -8.75 30.40% | -0.88 90.00% | -1.54 75.54% | -768.09 49,889.46% | |
ev to operating cash flow | -17.03 - | -18.84 10.59% | -10.12 46.27% | -1.14 88.78% | -2.12 86.50% | -2.02K 95,194.66% | |
ev to sales | 13.30K - | 18.03K - | |||||
free cash flow per share | -1.58 - | -1.92 21.55% | -2.78 44.42% | -1.74 37.43% | -1.91 10.21% | -0.00 99.95% | |
free cash flow yield | -0.06 - | -0.08 21.55% | -0.10 25.78% | -0.25 150.55% | -0.49 98.55% | -0.00 99.88% | |
graham net net | -2.50 - | -3.99 59.56% | 8.67 317.04% | 4.98 42.58% | 3.19 35.81% | 0.00 99.95% | |
graham number | 9.29 - | 11.65 25.39% | 24.92 113.81% | 17.63 29.25% | 15.77 10.56% | 0.01 99.93% | |
income quality | 0.79 - | 0.66 16.22% | 0.87 32.38% | 0.77 11.53% | 0.75 2.71% | 0.42 44.44% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -137.25 - | -2.38K 1,635.55% | -31.08 98.70% | -11.59 62.69% | |||
interest debt per share | 0.02 - | 1.44 6,525.58% | 1.48 3.31% | 0.00 99.89% | |||
inventory turnover | |||||||
invested capital | 0.21 - | 0.29 36.61% | 0.48 66.62% | ||||
market cap | 486.21M - | 775.00M 59.40% | 772.72M 0.29% | 398.57M 48.42% | 228.39M 42.70% | 106.40B 46,485.71% | |
net current asset value | -48.18M - | -122.58M 154.39% | 241.59M 297.10% | 284.16M 17.62% | 193.25M 31.99% | 100.99M 47.74% | |
net debt to ebitda | 0.20 - | 0.25 26.16% | 0.78 210.82% | 2.47 218.73% | 0.08 96.71% | -0.23 379.50% | |
net income per share | -1.82 - | -1.92 5.72% | -2.81 46.02% | -2.04 27.43% | -2.27 11.59% | -0.00 99.91% | |
operating cash flow per share | -1.43 - | -1.29 9.98% | -2.57 100.21% | -1.63 36.62% | -1.76 8.08% | -0.00 99.95% | |
payables turnover | |||||||
receivables turnover | 0.03 - | ||||||
research and ddevelopement to revenue | 782 - | 15.86 - | |||||
return on tangible assets | -0.43 - | -1.43 233.98% | -0.26 81.84% | -0.24 7.52% | -0.35 45.97% | -0.34 3.77% | |
revenue per share | 0.00 - | 0.00 - | |||||
roe | 0.86 - | 0.61 28.91% | -0.29 146.64% | -0.30 5.24% | -0.47 55.67% | -0.62 33.30% | |
roic | 0.93 - | 0.62 33.43% | -0.29 146.24% | -0.21 26.64% | -0.31 45.11% | -0.35 13.48% | |
sales general and administrative to revenue | 254.94 - | 8.61 - | |||||
shareholders equity per share | -2.11 - | -3.14 48.72% | 9.83 413.06% | 6.78 31.04% | 4.86 28.32% | 0.00 99.94% | |
stock based compensation to revenue | 96.89 - | 4.12 - | |||||
tangible asset value | -41.59M - | -98.59M 137.05% | 268.01M 371.84% | 381.75M 42.44% | 282.49M 26.00% | 203.13M 28.09% | |
tangible book value per share | -2.11 - | -3.14 48.72% | 9.83 413.06% | 6.78 31.04% | 4.86 28.32% | 0.00 99.94% | |
working capital | 70.37M - | 9.00M 87.21% | 256.51M 2,750.80% | 360.38M 40.49% | 267.87M 25.67% | 232.70M 13.13% |
All numbers in (except ratios and percentages)